Jamie Lynn Felton

This study investigates how altered B cell metabolic pathways, particularly HIF-1 signaling, contribute to Type 1 Diabetes progression by shifting B cell differentiation toward inflammatory subsets.

This study shows that TYK2 inhibitors reduce islet inflammation and delay type 1 diabetes onset in mice by modulating immune and endocrine responses.